Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

G. Mangili, R. Cioffi, S. Danese, L. Frigerio, G. Ferrandina, G. Cormio, E. Rabaiotti, G. Scarfone, A. Gadducci, A. Bergamini, C. Pisano, M. Candiani

Research output: Contribution to journalArticlepeer-review

Cite this